Holen Sie sich die Stockscreener-App
0.2546
7.70%
0.0182
Schlusskurs vom Vortag:
$0.2364
Offen:
$0.238
24-Stunden-Volumen:
649.75K
Relative Volume:
0.28
Marktkapitalisierung:
$30.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+10.22%
1M Leistung:
-19.94%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.23
$0.265
1-Wochen-Bereich:
$0.215
$0.265
52-Wochen-Spanne:
$0.205
$6.43
Pomdoctor Ltd Adr Stock (POM) Company Profile
Firmenname
Pomdoctor Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare POM vs HITI, PETS, WGRX, RDGT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
POM
Pomdoctor Ltd Adr
|
0.2546 | 28.18M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.31 | 202.91M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.18 | 62.70M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
WGRX
Wellgistics Health Inc
|
0.2788 | 28.76M | 28.99M | -39.20M | -3.34M | 0.00 |
|
RDGT
Ridgetech Inc
|
1.42 | 30.90M | 119.97M | -1.45M | 632.50K | -0.9847 |
Pomdoctor Ltd Adr Aktie (POM) Neueste Nachrichten
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Barchart.com
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Sahm
Shareholders who lost money in American Depositary Receipts - GlobeNewswire
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit - ChartMill
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of POMDOCTOR LIMITED (POM) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - GlobeNewswire Inc.
ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM) - ChartMill
Pomdoctor Deepens Medical Insurance Integration to Expand Online Chronic-Care Reach Across Major Chinese Cities - TipRanks
POM SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
Pomdoctor Receives Nasdaq Deficiency Notice Over Minimum Bid Price - TipRanks
Pomdoctor expands online hospital business through pharma partnerships By Investing.com - Investing.com India
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China - TipRanks
United States shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative - Sahm
Pomdoctor Limited Reports Strong Revenue Growth Amidst Challenging Conditions - TipRanks
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
Citi (NYSE: C) extends Token Services in Dublin with Euro transfers, 24/7 liquidity - Stock Titan
Citi (NYSE: C) lowers base lending rate to 7.00%, effective Oct 30 at Citibank, N.A. - Stock Titan
Diluted shares outstanding of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - The AI Journal
Citigroup (NYSE:C) Stock Quote - FinancialContent
Free cash flow per share of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Citigroup Reports Third Quarter 2025 Results - Business Wire
Q3 2025 Results: Citigroup Reports Results; Webcast & Conference Call at 11 a.m. ET Today - Stock Titan
Earnings calendar for: - Yahoo
$0.60 Quarterly Dividend: Citigroup to Pay Nov 26; Multiple Preferred Series Payments Announced - Stock Titan
Debt to assets ratio of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Gross margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Balance Sheet – BOATS:POM - TradingView
Operating margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Diluted earnings per share (Diluted EPS) of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Income Statement – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Statistics – BOATS:POM - TradingView
Diluted net income available to common stockholders of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Financial Statements – BOATS:POM - TradingView
EBIT of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Diluted earnings per share (Diluted EPS) of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Total assets of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Earnings and Revenue – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Revenue Breakdown – BOATS:POM - TradingView
Gross profit of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Operating expenses (excl. COGS) of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
EBITDA of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Should You Buy POM Stock After The PomDoctor IPO? - Barchart.com
Pomdoctor Limited (POM) Stock Price, News, Quote & History - Yahoo
Cash from financing activities of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Number of employees of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Finanzdaten der Pomdoctor Ltd Adr-Aktie (POM)
Es liegen keine Finanzdaten für Pomdoctor Ltd Adr (POM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):